AstraZeneca's new wonderdrug produces 'significant reduction' in severe Covid and death

    [ad_1]

    The group’s treatment, known as AZD7442, is a combination of two antibodies and has been undergoing final clinical trials.

    AstraZeneca has announced it achieved a “statistically significant reduction in severe COVID-19 or death” in non-hospitalised patients with mild-to-moderate symptoms.

    MORE TO FOLLOW



    [ad_2]

    Previous articleBillie Eilish sees streams of her No Time To Die theme song PLUMMET
    Next articleExperts identify oldest footprints of pre-humans in Crete

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here